TuHURA Biosciences
HURA
9 hedge funds and large institutions have $682K invested in TuHURA Biosciences in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.
603% more capital invested
Capital invested by funds: $97K → $682K (+$585K)
80% more funds holding
Funds holding: 5 → 9 (+4)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$786K |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$165K |
| 3 |
Barclays
London,
United Kingdom
|
+$29.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$19.4K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$9.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TFS
TrustCore Financial Services
Brentwood,
Tennessee
|
-$4K |
HURA Hedge Fund Activity: Q4 2018 in Review
9 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q4 2018, worth a combined $682K — up 603% from $97K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new HURA positions and 0 closed out — a net gain of 4 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $786K. The largest seller was TrustCore Financial Services, cutting an estimated $4K.
- 9 institutional investors held TuHURA Biosciences (HURA) as of Q4 2018, up from 5 in Q3 2018.
- Funds reported $682K of TuHURA Biosciences stock for Q4 2018, up 603% quarter-over-quarter.
- 4 funds opened new TuHURA Biosciences positions in Q4 2018 and 0 closed out, a net change of +4 holders.
- The largest TuHURA Biosciences buyer in Q4 2018 was Sabby Management, an estimated $786K added.
- The largest TuHURA Biosciences seller in Q4 2018 was TrustCore Financial Services, an estimated $4K sold.
Based on aggregated 13F filings for Q4 2018.